Assessment of drug–drug interaction potential with EDP‐305, a farnesoid X receptor agonist, in healthy subjects

por Ahmad, Alaa, Adda, Nathalie
Publicado 2022

Incidence and Resistotyping Profiles of Bacillus subtilis Isolated from Azadi Teaching Hospital in Duhok City, Iraq

por Yassin, Najim Abdulla, Ahmad, Alaa Muyassar
Publicado 2012

EDP‐297: A novel, farnesoid X receptor agonist—Results of a phase I study in healthy subjects

por Marotta, Christine, Ahmad, Alaa, Luo, Ed, Oosterhaven, Jart, van Marle, Sjoerd, Adda, Nathalie
Publicado 2022

923. EDP-938, A Respiratory Syncytial Virus (RSV) antiviral, demonstrates a high barrier to resistance in a human challenge study

por Levene, Rachel E, DeVincenzo, John, Conery, Annie, Ahmad, Alaa, Goodwin, Bryan, Or, Yat Sun, Rhodin, Michael
Publicado 2023

Mental health literacy among pediatric hospital staff in the United Arab Emirates

por Al-Yateem, Nabeel, Rossiter, Rachel, Robb, Walter, Ahmad, Alaa, Elhalik, Mahmoud Saleh, Albloshi, Sumaya, Slewa-Younan, Shameran
Publicado 2017

Nurse-identified patient care and health services research priorities in the United Arab Emirates: a Delphi study

por Al-Yateem, Nabeel, Al-Tamimi, Muna, Brenner, Maria, Al Tawil, Hanan, Ahmad, Alaa, Brownie, Sharon, Slewa-Younan, Shameran
Publicado 2019

LB6. EDP-938, a Novel RSV N-Inhibitor, Administered Once or Twice Daily Was Safe and Demonstrated Robust Antiviral and Clinical Efficacy in a Healthy Volunteer Challenge Study

por Coakley, Eoin, Ahmad, Alaa, Larson, Kajal, McClure, Ty, Lin, Kai, Lin, Kai, Tenhoor, Kursten, Eze, Kingsley, Noulin, Nicolas, Horvathova, Veronika, Murray, Bryan, Baillet, Mark, Mori, Julie, Adda, Nathalie
Publicado 2019

Anti-MAdCAM Antibody Increases ß7+ T Cells and CCR9 Gene Expression in the Peripheral Blood of Patients With Crohn’s Disease

por Hassan-Zahraee, Mina, Banerjee, Anindita, Cheng, John B, Zhang, Weidong, Ahmad, Alaa, Page, Karen, von Schack, David, Zhang, Baohong, Martin, Steven W, Nayak, Satyaprakash, Reddy, Padma, Xi, Li, Neubert, Hendrik, Fernandez Ocana, Mireia, Gorelick, Ken, Clare, Robert, Vincent, Michael, Cataldi, Fabio, Hung, Kenneth
Publicado 2018

Phase II evaluation of anti-MAdCAM antibody PF-00547659 in the treatment of Crohn’s disease: report of the OPERA study

por Sandborn, William J, Lee, Scott D, Tarabar, Dino, Louis, Edouard, Klopocka, Maria, Klaus, Jochen, Reinisch, Walter, Hébuterne, Xavier, Park, Dong-Il, Schreiber, Stefan, Nayak, Satyaprakash, Ahmad, Alaa, Banerjee, Anindita, Brown, Lisa S, Cataldi, Fabio, Gorelick, Kenneth J, Cheng, John B, Hassan-Zahraee, Mina, Clare, Robert, D’Haens, Geert R
Publicado 2018

Anti-MAdCAM-1 antibody (PF-00547659) for active refractory Crohn’s disease in Japanese and Korean patients: the OPERA study

por Saruta, Masayuki, Park, Dong Il, Kim, Young-Ho, Yang, Suk-Kyun, Jang, Byung-Ik, Cheon, Jae Hee, Im, Jong Pil, Kanai, Takanori, Katsuno, Tatsuro, Ishiguro, Yoh, Nagaoka, Makoto, Isogawa, Naoki, Li, Yinhua, Banerjee, Anindita, Ahmad, Alaa, Hassan-Zahraee, Mina, Clare, Robert, Gorelick, Kenneth J., Cataldi, Fabio, Watanabe, Mamoru, Hibi, Toshifumi
Publicado 2020

Effect of PF-00547659 on Central Nervous System Immune Surveillance and Circulating β7+ T Cells in Crohn’s Disease: Report of the TOSCA Study

por D’Haens, Geert, Vermeire, Séverine, Vogelsang, Harald, Allez, Matthieu, Desreumaux, Pierre, Van Gossum, Andre, Sandborn, William J, Baumgart, Daniel C, Ransohoff, Richard M, Comer, Gail M, Ahmad, Alaa, Cataldi, Fabio, Cheng, John, Clare, Robert, Gorelick, Kenneth J, Kaminski, Annamarie, Pradhan, Vivek, Rivers, Sunday, Sikpi, Matthew O, Zhang, Yanhua, Hassan-Zahraee, Mina, Reinisch, Walter, Stuve, Olaf
Publicado 2018